Tag: Lantus
FiercePharmaAsia—Biocon, Mylan’s Lantus copy; Samsung rides COVID demand; Adlai Nortye’s C...
Mylan and Biocon will launch Semglee, their biosimilar of Sanofi's Lantus, at a discount. Samsung Biologics' $2 billion "Super Plant" expansion is the result...
ADA: Novo Nordisk’s long-lasting insulin candidate matches Lantus in phase 2
Novo Nordisk has long been working on drugs that can help people earlier on in their diabetes and keep them from progressing to insulin...
